Supply of NAT instruments and reagents for blood screening.
The procurement concerns the supply of nucleic acid testing (NAT) instruments and reagents for blood screening. The buyer is a Swedish healthcare entity, likely serving blood banks or transfusion services. Requirements include CE marking and compliance with EU directives for in vitro diagnostic medical devices. The contract is for a multi-year period with an estimated value between 1 million and 10 million EUR. Suppliers must demonstrate experience in providing NAT systems for blood screening.